A citation-based method for searching scientific literature

Youlia M Kirova, Dominique Stoppa-Lyonnet, Alexia Savignoni, Brigitte Sigal-Zafrani, Nicolas Fabre, Alain Fourquet. Eur J Cancer 2005
Times Cited: 90

List of co-cited articles
860 articles co-cited >1

Times Cited
  Times     Co-cited

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.
Lori J Pierce, Albert M Levin, Timothy R Rebbeck, Merav A Ben-David, Eitan Friedman, Lawrence J Solin, Eleanor E Harris, David K Gaffney, Bruce G Haffty, Laura A Dawson,[...]. J Clin Oncol 2006

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.
Bruce G Haffty, Elizabeth Harrold, Atif J Khan, Pradip Pathare, Tanya E Smith, Bruce C Turner, Peter M Glazer, Barbara Ward, Daryl Carter, Ellen Matloff,[...]. Lancet 2002

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan,[...]. J Clin Oncol 2004

Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.
L J Pierce, M Strawderman, S A Narod, I Oliviotto, A Eisen, L Dawson, D Gaffney, L J Solin, A Nixon, J Garber,[...]. J Clin Oncol 2000

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.
Mark E Robson, Pierre O Chappuis, Jaya Satagopan, Nora Wong, Jeff Boyd, John R Goffin, Clifford Hudis, David Roberge, Larry Norton, Louis R Bégin,[...]. Breast Cancer Res 2004

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
C T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, A vd Ouweland, M B E Menke-Pluymers, C C M Bartels, M Kriege, A N van Geel, C W Burger, A M M Eggermont,[...]. Eur J Cancer 2007

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.
M Robson, D Levin, M Federici, J Satagopan, F Bogolminy, A Heerdt, P Borgen, B McCormick, C Hudis, L Norton,[...]. J Natl Cancer Inst 1999

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.
C Seynaeve, L C Verhoog, L M C van de Bosch, A N van Geel, M Menke-Pluymers, E J Meijers-Heijboer, A M W van den Ouweland, A Wagner, C L Creutzberg, M F Niermeijer,[...]. Eur J Cancer 2004

Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
Mark Robson, Tiffany Svahn, Beryl McCormick, Patrick Borgen, Clifford A Hudis, Larry Norton, Kenneth Offit. Cancer 2005

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
Lori J Pierce, Kelly-Anne Phillips, Kent A Griffith, Saundra Buys, David K Gaffney, Meena S Moran, Bruce G Haffty, Merav Ben-David, Bella Kaufman, Judy E Garber,[...]. Breast Cancer Res Treat 2010

Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
Carlos A Garcia-Etienne, Monica Barile, Oreste D Gentilini, Edoardo Botteri, Nicole Rotmensz, Andrea Sagona, Gabriel Farante, Viviana Galimberti, Alberto Luini, Paolo Veronesi,[...]. Ann Surg Oncol 2009

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer.
P O Chappuis, J Goffin, N Wong, C Perret, P Ghadirian, P N Tonin, W D Foulkes. J Med Genet 2002

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.
L C Verhoog, C T Brekelmans, C Seynaeve, L M van den Bosch, G Dahmen, A N van Geel, M M Tilanus-Linthorst, C C Bartels, A Wagner, A van den Ouweland,[...]. Lancet 1998

Survival and prognostic factors in BRCA1-associated breast cancer.
C T M Brekelmans, C Seynaeve, M Menke-Pluymers, H T Brüggenwirth, M M A Tilanus-Linthorst, C C M Bartels, M Kriege, A N van Geel, C M G Crepin, J C Blom,[...]. Ann Oncol 2006

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Youlia M Kirova, Alexia Savignoni, Brigitte Sigal-Zafrani, Anne de La Rochefordiere, Rémy J Salmon, Pascale This, Bernard Asselain, Dominique Stoppa-Lyonnet, Alain Fourquet. Breast Cancer Res Treat 2010

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
M Clarke, R Collins, S Darby, C Davies, P Elphinstone, V Evans, J Godwin, R Gray, C Hicks, S James,[...]. Lancet 2005

Survival in hereditary breast cancer associated with germline mutations of BRCA2.
L C Verhoog, C T Brekelmans, C Seynaeve, G Dahmen, A N van Geel, C C Bartels, M M Tilanus-Linthorst, A Wagner, P Devilee, D J Halley,[...]. J Clin Oncol 1999

Familial invasive breast cancers: worse outcome related to BRCA1 mutations.
D Stoppa-Lyonnet, Y Ansquer, H Dreyfus, C Gautier, M Gauthier-Villars, E Bourstyn, K B Clough, H Magdelénat, P Pouillart, A Vincent-Salomon,[...]. J Clin Oncol 2000

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
Gad Rennert, Shantih Bisland-Naggan, Ofra Barnett-Griness, Naomi Bar-Joseph, Shiyu Zhang, Hedy S Rennert, Steven A Narod. N Engl J Med 2007

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.
Umberto Veronesi, Natale Cascinelli, Luigi Mariani, Marco Greco, Roberto Saccozzi, Alberto Luini, Marisel Aguilar, Ettore Marubini. N Engl J Med 2002

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.
Bernard Fisher, Stewart Anderson, John Bryant, Richard G Margolese, Melvin Deutsch, Edwin R Fisher, Jong-Hyeon Jeong, Norman Wolmark. N Engl J Med 2002

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.
W D Foulkes, P O Chappuis, N Wong, J S Brunet, D Vesprini, F Rozen, Z Q Yuan, M N Pollak, G Kuperstein, S A Narod,[...]. Ann Oncol 2000

Familial breast cancer: an investigation into the outcome of treatment for early stage disease.
D Eccles, P Simmonds, J Goddard, M Coultas, S Hodgson, F Lalloo, G Evans, N Haites. Fam Cancer 2001

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998

BRCA-associated breast cancer in young women.
M Robson, T Gilewski, B Haas, D Levin, P Borgen, P Rajan, Y Hirschaut, P Pressman, P P Rosen, M L Lesser,[...]. J Clin Oncol 1998

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.
John R Goffin, Pierre O Chappuis, Louis R Bégin, Nora Wong, Jean-Sébastien Brunet, Nancy Hamel, Ann-Josée Paradis, Jeff Boyd, William D Foulkes. Cancer 2003

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
S R Lakhani, J Jacquemier, J P Sloane, B A Gusterson, T J Anderson, M J van de Vijver, L M Farid, D Venter, A Antoniou, A Storfer-Isser,[...]. J Natl Cancer Inst 1998

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011

Improved survival in women with BRCA-associated ovarian carcinoma.
Ilana Cass, Rae Lynn Baldwin, Taz Varkey, Roxana Moslehi, Steven A Narod, Beth Y Karlan. Cancer 2003

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001

Survival and recurrence after breast cancer in BRCA1/2 mutation carriers.
Mahmoud El-Tamer, Donna Russo, Andrea Troxel, Lourdes P Bernardino, Robert Mazziotta, Alison Estabrook, Beth-Ann Ditkoff, Freya Schnabel, Mahesh Mansukhani. Ann Surg Oncol 2004

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer.
L C Verhoog, C T Brekelmans, C Seynaeve, E J Meijers-Heijboer, J G Klijn. Br J Cancer 2000

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Monika K Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G Froster, Bettina Schlehe, Astrid Bechtold, Norbert Arnold,[...]. J Clin Oncol 2009

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990

The role of BRCA1 in the cellular response to chemotherapy.
Richard D Kennedy, Jennifer E Quinn, Paul B Mullan, Patrick G Johnston, D Paul Harkin. J Natl Cancer Inst 2004

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994

Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations.
D K Gaffney, R M Brohet, C M Lewis, J A Holden, S S Buys, S L Neuhausen, L Steele, V Avizonis, J R Stewart, L A Cannon-Albright. Radiother Oncol 1998

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994

The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.
André Fedier, Rolf A Steiner, Viola A Schwarz, Lenka Lenherr, Urs Haller, Daniel Fink. Int J Oncol 2003

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.
Jennifer E Quinn, Richard D Kennedy, Paul B Mullan, Paula M Gilmore, Michael Carty, Patrick G Johnston, D Paul Harkin. Cancer Res 2003

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.